Lunai Bioworks Inc.【LNAI】

時価総額

$3173.9万

PER

マルチオミクス解析とAI診断プラットフォームの新興企業。液体生検を含むマルチモーダル解析とOxford Nanopore採用のシーケンシングサービスを展開。GEDi Cubeを2024年2月13日に買収、CLIA/ISO認証ラボ設置計画。オランダを起点にEMEA・米国展開。

株価業績

サマリーテーブルに戻る

	2018年 6月30日	2019年 6月30日	2021年 6月30日	2022年 6月30日	2023年 6月30日	2024年 6月30日
Cash	16	12	21	9	2	220,467
Insurance receivable	-	-	-	-	-	1
Prepaids and other assets	-	-	-	392,996	690,925	668,929
Total Current Assets	16	12	21	10	3	2
Property and equipment, net	27,402	687,517	719,364	586,536	508,989	482,121
Definite life intangible assets, net	152	93,299	65,906	44,268	39,676	30,043
Indefinite life intangible assets, net	-	155	155	62	43	-
Goodwill	12	12	12	12	12	159
Deposits and other assets	137,550	137,550	20,984	68,635	21,741	19,849
Operating lease right-of-use assets	-	-	1	1	913,985	1
Total Other Assets	-	-	168	74	55	161
TOTAL ASSETS	180	180	190	85	58	163
Accounts payable – trade	571,809	538,563	320,559	1	5	9
Accrued expenses	66,913	336,853	1	1	723,173	5
Other current liabilities	-	-	90,602	220,685	184,733	295,361
Contingent consideration liability	-	-	-	-	-	12
Convertible notes payable	-	-	1	-	-	245,000
Current portion of operating lease liabilities	-	-	292,409	253,636	193,422	493,553
Notes payable – related parties, net	-	-	-	-	-	2
Total Current Liabilities	873,722	1	2	6	11	30
Operating lease liabilities, net of current portion	-	-	1	985,699	775,587	842,389
Total Non-Current Liabilities	23	6	15	6	775,587	842,389
Total Liabilities	24	7	-	12	12	31
Common stock, par value $0.0001, 350,000,000 shares authorized, 155,027,245 shares issued and outstanding at June 30, 2024; 63,698,144 shares issued and outstanding at June 30, 2023	3,616	4,527	5,222	5,302	6,371	15,504
Additional paid-in capital	193	226	266	277	291	457
Accumulated deficit	-37,595,389	-52,771,840	-90,911,805	-204,345,197	-244,029,253	-324,679,425
Accumulated other comprehensive (loss)	205,680	101,818	-10,834	-30,436	-29,882	-170,846
Total Stockholders’ Equity	156	173	175	73	47	132
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	180	180	190	85	58	163